An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function

Scroggins, Bradley T., Robzyk, Kenneth, Wang, Dongxia, Marcu, Monica G., Tsutsumi, Shinji, Beebe, Kristin, Cotter, Robert J., Felts, Sara, Toft, David, Karnitz, Larry, Rosen, Neal, Neckers, Len·2007·Molecular Cell
DOI 10.1016/j.molcel.2006.12.008

Cited by (421)

Items 101–200 of 421

  1. Specific Arabidopsis HSP90.2 alleles recapitulate RAR1 cochaperone function in plant NB-LRR disease resistance protein regulation
    David A. Hubert, Yijian He, Brian C. McNulty, Pablo Tornero, Jeffery L. Dangl · 2009 · Proceedings of the National Academy of Sciences
  2. Cross-talk between Sirtuin and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in the Regulation of S6 Kinase 1 (S6K1) Phosphorylation
    Sungki Hong, Bin Zhao, David B. Lombard, Diane C. Fingar, Ken Inoki · 2014 · Journal of Biological Chemistry
  3. The fungal Achilles’ heel: targeting Hsp90 to cripple fungal pathogens
    Leah E. Cowen · 2013 · Current Opinion in Microbiology
  4. Regulation of molecular chaperones through post-translational modifications: Decrypting the chaperone code
    Philippe Cloutier, Benoit Coulombe · 2013 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  5. HDAC6: A unique HDAC family member as a cancer target
    Sumeet Kaur, Prerna Rajoria, Madhu Chopra · 2022 · Cellular Oncology
  6. Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease
    Jie Lu, Chunzhang Yang, Masako Chen, Donald Y. Ye, Russell R. Lonser, Roscoe O. Brady, Zhengping Zhuang · 2011 · Proceedings of the National Academy of Sciences
  7. Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis
    Robin Winkler, Verena Benz, Markus Clemenz, M Bloch, Anna Foryst‐Ludwig, Sami Wardat, Nicole Witte, Manuela Trappiel, Pawel Namsolleck, Knut Mai et al. · 2011 · Diabetes
  8. Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity
    Haijuan Wang, Michael P. Holloway, Li Ma, Zachary Aaron Cooper, Matthew Riolo, Ayman Samkari, Kojo S.J. Elenitoba‐Johnson, Yue Eugene Chin, Rachel A. Altura · 2010 · Journal of Biological Chemistry
  9. HDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1α, and Hsc70
    Liqing Luo, Sherry C. Martin, Jascha D. Parkington, Samuel M. Cadena, Jiang Zhu, Chikwendu Ibebunjo, Serge Summermatter, Nicole Londraville, Krystyna Patora‐Komisarska, Leo Widler et al. · 2019 · Cell Reports
  10. Inhibitors of Deacetylases Suppress Oncogenic KIT Signaling, Acetylate HSP90, and Induce Apoptosis in Gastrointestinal Stromal Tumors
    Thomas Mühlenberg, Yixiang Zhang, Andrew J. Wagner, Florian Grabellus, James E. Bradner, G. Taeger, Hauke Lang, Takahiro Taguchi, Martin Schüler, Jonathan Alfred Fletcher et al. · 2009 · Cancer Research
  11. Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy
    Jana Franke, Simone Eichner, Carsten Zeilinger, Andreas Kirschning · 2013 · Natural Product Reports
  12. Posttranslational Modification and Quality Control
    Xuejun Wang, J. Scott Pattison, Huabo Su · 2013 · Circulation Research
  13. The enhancement of antiproliferative and proapoptotic activity of HDAC inhibitors by curcumin is mediated by Hsp90 inhibition
    Chiara Giommarelli, Valentina Zuco, Enrica Favini, Claudio Pisano, Fabrizio Dal Piaz, Nunziatina De Tommasi, Franco Zunino · 2009 · Cellular and Molecular Life Sciences
  14. Inhibition of Apoptosome Formation by Suppression of Hsp90β Phosphorylation in Tyrosine Kinase-Induced Leukemias
    Manabu Kurokawa, Chen Zhao, Tannishtha Reya, Sally A. Kornbluth · 2008 · Molecular and Cellular Biology
  15. Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer
    Zohaib Rana, Sarah D. Diermeier, Muhammad Hanif, Rhonda J. Rosengren · 2020 · Biomedicines
  16. Histone Deacetylase Inhibitor (HDACi) Suberoylanilide Hydroxamic Acid (SAHA)-mediated Correction of α1-Antitrypsin Deficiency
    Marion Bouchecareilh, Darren M. Hutt, Patricia Szajner, Terence R. Flotte, William E. Balch · 2012 · Journal of Biological Chemistry
  17. Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain
    Shinji Tsutsumi, Mehdi Mollapour, C. Graf, Chung‐Tien Lee, Bradley T. Scroggins, Wanping Xu, Lenka Haslerova, Martin Heßling, Anna A Konstantinova, Jane B. Trepel et al. · 2009 · Nature Structural & Molecular Biology
  18. MEC-17 Deficiency Leads to Reduced α-Tubulin Acetylation and Impaired Migration of Cortical Neurons
    Lei Li, Dan Wei, Qiong Wang, Jing Pan, Rong Liu, Xu Zhang, Lan Bao · 2012 · Journal of Neuroscience
  19. HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis
    Ryu, Hyun-Wook, Shin, Dong-Hee, Lee, Dong Hoon, Choi, Junjeong, Han, Gyoonhee, Lee, Kang Young, Kwon, So Hee · 2017 · Cancer Letters
  20. MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells
    Chie Nishioka, Takayuki Ikezoe, Jing Yang, Seisho Takeuchi, Harold Phillip Koeffler, Akihito Yokoyama · 2008 · Leukemia Research
  21. The Fasted/Fed Mouse Metabolic Acetylome: N6-Acetylation Differences Suggest Acetylation Coordinates Organ-Specific Fuel Switching
    Yang Li, Bhavapriya Vaitheesvaran, Kirsten Hartil, Alan J. Robinson, Michael R. Hoopmann, Jimmy K. Eng, Irwin J. Kurland, James E. Bruce · 2011 · Journal of Proteome Research
  22. Alcohol-induced Hsp90 acetylation is a novel driver of liver sinusoidal endothelial dysfunction and alcohol-related liver disease
    Yilin Yang, Panjamaporn Sangwung, Reiichiro Kondo, Yirang Jung, Matthew J. McConnell, Jain Jeong, Teruo Utsumi, William C. Sessa, Yasuko Iwakiri · 2021 · Journal of Hepatology
  23. Tubulin acetylation favors Hsp90 recruitment to microtubules and stimulates the signaling function of the Hsp90 clients Akt/PKB and p53
    Julien Giustiniani, Vanessa Daire, Isabelle Cantaloube, Geneviève Durand, Christian Poüs, Daniel Perdiz, Anita Baillet · 2008 · Cellular Signalling
  24. Class-Specific Histone/Protein Deacetylase Inhibition Protects Against Renal Ischemia Reperfusion Injury and Fibrosis Formation
    Matthew H. Levine, Zhiyue Wang, Tricia R Bhatti, Yanfeng Wang, David D. Aufhauser, Sa’Rah McNeal, Y. Liu, Shayan Cheraghlou, Rongxiang Han, Li-San Wang et al. · 2015 · American Journal of Transplantation
  25. Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones
    Chunzhang Yang, Shervin Rahimpour, Jie Lu, Karel Pacák, Barbara L. Ikejiri, Roscoe O. Brady, Zhengping Zhuang · 2012 · Proceedings of the National Academy of Sciences
  26. The network interaction of the human cytosolic 90kDa heat shock protein Hsp90: A target for cancer therapeutics
    Viviane C. H. da Silva, Carlos H.I. Ramos · 2012 · Journal of Proteomics
  27. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90
    Ping Liu, Ji Xiao, Yiliang Wang, Xiaowei Song, Lianzhou Huang, Zhe Ren, Kaio Kitazato, Yifei Wang · 2021 · Molecular Medicine
  28. Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression
    Alejandra G. Erlejman, Mariana Lagadari, Judith Toneatto, Graciela Piwien‐Pilipuk, Mario D. Galigniana · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  29. Identification of a Key Lysine Residue in Heat Shock Protein 90 Required for Azole and Echinocandin Resistance in Aspergillus fumigatus
    Lamoth, Frédéric, Juvvadi, Praveen R., Soderblom, Erik J., Moseley, M. Arthur, Asfaw, Yohannes G., Steinbach, William J. · 2014 · Antimicrobial Agents and Chemotherapy
  30. 5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer’s Disease Phenotypes
    Hsueh‐Yun Lee, Sheng-Jun Fan, Fang-I Huang, Hsin-Yi Chao, Kai‐Cheng Hsu, Tony Eight Lin, Teng‐Kuang Yeh, Mei-Jung Lai, Yu-Hsuan Li, Hsiang-Ling Huang et al. · 2018 · Journal of Medicinal Chemistry
  31. HDAC 6 at the Intersection of Neuroprotection and Neurodegeneration
    Constantin van Outryve d’Ydewalle, Elke Bogaert, Ludo Van Den Bosch · 2012 · Traffic
  32. Acetylation of αA-crystallin in the human lens: Effects on structure and chaperone function
    Ram H. Nagaraj, Rooban B. Nahomi, Shilpa Shanthakumar, Mikhail D. Linetsky, Smitha Padmanabha, Nagarekha Pasupuleti, Benlian Wang, Puttur Santhoshkumar, Alok Kumar Panda, Ashis Biswas · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  33. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss
    Tara E. Tracy, Li Gan · 2017 · BioEssays
  34. Acetylation and deacetylation—novel factors in muscle wasting
    Nima Alamdari, Zaira Aversa, Estíbaliz Castillero, Per-Olof J. Hasselgren · 2012 · Metabolism
  35. Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme
    Gang Wang, Junjie Wang, Xingli Fu, Rui Guang, Shing-shun Tony To · 2016 · Oncology Reports
  36. The Mechanism of Hsp90 ATPase Stimulation by Aha1
    Wolmarans, Annemarie, Lee, Brian, Spyracopoulos, Leo, LaPointe, Paul · 2016 · Scientific Reports
  37. Post-translational modification and conformational state of Heat Shock Protein 90 differentially affect binding of chemically diverse small molecule inhibitors
    Kristin E. Beebe, Mehdi Mollapour, Bradley T. Scroggins, Chrisostomos Prodromou, Wanping Xu, Mari Tokita, Tony Taldone, Lester Pullen, Bettina K. Zierer, Min-Jung Lee et al. · 2013 · Oncotarget
  38. Epigenetic regulation of androgen receptor signaling in prostate cancer
    Lina Gao, Joshi J. Alumkal · 2010 · Epigenetics
  39. Glioblastoma multiforme: novel therapeutic targets
    Matthew T. Muir, Sricharan Gopakumar, Jeffrey Isaac Traylor, Sungho Lee, Ganesh Rao · 2020 · Expert Opinion on Therapeutic Targets
  40. Protein Targets of Thioacetamide Metabolites in Rat Hepatocytes
    Yakov M. Koen, Diganta Sarma, Heather Hajovsky, Nadezhda A. Galeva, Todd D. Williams, Jeffrey L. Staudinger, Robert P. Hanzlik · 2013 · Chemical Research in Toxicology
  41. Tau Phosphorylation, Molecular Chaperones, and Ubiquitin E3 Ligase: Clinical Relevance in Alzheimer's Disease
    Pravir Kumar, Niraj Kumar Jha, Saurabh Kumar Jha, Karunya Ramani, Rashmi K. Ambasta · 2014 · Journal of Alzheimer s Disease
  42. A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
    Kaliszczak, M, Trousil, S, Åberg, O, Perumal, M, Nguyen, Q-D, Aboagye, E O · 2013 · British Journal of Cancer
  43. Subcellular Localization of Class II HDAs in Arabidopsis thaliana: Nucleocytoplasmic Shuttling of HDA15 Is Driven by Light
    Malona V. Alinsug, Fang Fang Chen, Ming Luo, Ready Tai, Liwen Jiang, Keqiang Wu · 2012 · PLoS ONE
  44. Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG‐positive prostate cancer
    Mari L. Björkman, Kristiina Iljin, Pasi Halonen, Henri Sara, Elisa Kaivanto, Matthias Nees, Olli Kallioniemi · 2008 · International Journal of Cancer
  45. Endoplasmic Reticulum-associated Degradation of Niemann-Pick C1
    Naoe Nakasone, Yuko S. Nakamura, Katsumi Higaki, Nao Oumi, Kousaku Ohno, Haruaki Ninomiya · 2014 · Journal of Biological Chemistry
  46. HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
    Yue, Lanzhu, Sharma, Vasundhara, Horvat, Nathan P., Akuffo, Afua A., Beatty, Matthew S., Murdun, Cem, Colin, Christelle, Billington, Julia M. R., Goodheart, William E., Sahakian, Eva et al. · 2020 · Blood
  47. Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylate
    Yun Dai, Shuang Chen, Charis A. Venditti, Xin‐Yan Pei, Tri K. Nguyen, Paul Dent, Steven Grant · 2008 · Blood
  48. RETRACTED: Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
    Valentina Zuco, Michelandrea De Cesare, Raffaella Cincinelli, Raffaella Nannei, Claudio Pisano, Nadia Zaffaroni, Franco Zunino · 2011 · PLoS ONE · Retracted
  49. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer
    Carole Seidel, Michaël Schnekenburger, Aloran Mazumder, Marie-Hélène Teiten, Gilbert Kirsch, Mario A. Dicato, Marc F. Diederich · 2015 · Biochemical Pharmacology
  50. Contributions of Co-Chaperones and Post-Translational Modifications Towards Hsp90 Drug Sensitivity
    Annerleim Walton‐Diaz, Sahar Khan, Dimitra Bourboulia, Jane B. Trepel, Len Neckers, Mehdi Mollapour · 2013 · Future Medicinal Chemistry
  51. Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis
    Frédéric Lamoth, Praveen R. Juvvadi, William J. Steinbach · 2015 · Frontiers in Microbiology
  52. Deacetylase inhibitors - focus on non-histone targets and effects
    Matthias Ocker · 2010 · World Journal of Biological Chemistry
  53. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression
    Thomas D. Zaikos, Mark M. Painter, Nadia T. Sebastian, Valeri H. Terry, Kathleen L. Collins · 2018 · Journal of Virology
  54. Hsp90 middle domain phosphorylation initiates a complex conformational program to recruit the ATPase-stimulating cochaperone Aha1
    Wan-Ping Xu, K. Beebe, Juan D. Chavez, M. Boysen, Yinying Lu, A. Zuehlke, D. Keramisanou, J. Trepel, C. Prodromou, Matthias P. Mayer et al. · 2019 · Nature Communications
  55. Regulation of the Hsp90 system
    Siyuan Sima, Klaus Richter · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  56. Cellular Stress and General Pathological Processes
    Eugeny Yu. Gusev, Natalia V. Zotova · 2019 · Current Pharmaceutical Design
  57. Enhancement of Stress Resilience Through Histone Deacetylase 6–Mediated Regulation of Glucocorticoid Receptor Chaperone Dynamics
    Jeanine Jochems, Sarah L. Teegarden, Yong Chen, Janette Boulden, Collin Challis, Gabriel A. Ben-Dor, Sangwon F. Kim, Olivier Berton · 2014 · Biological Psychiatry
  58. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus
    Frédéric Lamoth, Praveen R. Juvvadi, William J. Steinbach · 2014 · Critical Reviews in Microbiology
  59. A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot–Marie–Tooth disease type 1A
    Nina Ha, Young Il Choi, Namhee Jung, Ju Young Song, Dae Kwon Bae, Min Cheol Kim, Yong Jae Lee, Hyeseung Song, Geon Kwak, Soyeon Jeong et al. · 2020 · British Journal of Pharmacology
  60. Drug design targeting active posttranslational modification protein isoforms
    Fanwang Meng, Zhongjie T. Liang, Kehao Zhao, Cheng Luo · 2020 · Medicinal Research Reviews
  61. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy
    Scott Thomas, Pamela N. Münster · 2009 · Cancer Letters
  62. Structural Basis of the Radicicol Resistance Displayed by a Fungal Hsp90
    Chrisostomos Prodromou, James M. Nuttall, Stefan H. Millson, Stephen Mark Roe, Tiow‐Suan Sim, Doreen Tan, Paul Workman, Laurence H. Pearl, Peter W. Piper · 2009 · ACS Chemical Biology
  63. Bioinformatic Analysis and Post-Translational Modification Crosstalk Prediction of Lysine Acetylation
    Zhike Lu, Zhongyi Cheng, Yingming Zhao, Samuel L. Volchenboum · 2011 · PLoS ONE
  64. Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic Emerges
    Peter W. Piper, Stefan H. Millson · 2011 · Pharmaceuticals
  65. Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy
    Chao Ding, Shaopeng Chen, Cunlong Zhang, Guangnan Hu, Wei Zhang, Lulu Li, Yu Chen, Chunyan Tan, Yuyang Jiang · 2016 · Bioorganic & Medicinal Chemistry
  66. Post-translational modification of heat-shock protein 90: impact on chaperone function
    Bradley T. Scroggins, Len Neckers · 2007 · Expert Opinion on Drug Discovery
  67. Do Epigenetic Events Take Place in the Vastus Lateralis of Patients with Mild Chronic Obstructive Pulmonary Disease?
    Ester Puig‐Vilanova, Pilar Ausín, Juana Martínez‐Llorens, Joaquim Gea, Esther Barreiro · 2014 · PLoS ONE
  68. Targeting histone deacetylases for the treatment of disease
    Matthew W. Lawless, Suzanne Norris, Kenneth John O'Byrne, Steven G. Gray · 2008 · Journal of Cellular and Molecular Medicine
  69. Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases
    Gary E. L. Brandt, Brian S. J. Blagg · 2009 · Current Topics in Medicinal Chemistry
  70. Dissecting Structure-Encoded Determinants of Allosteric Cross-Talk between Post-Translational Modification Sites in the Hsp90 Chaperones
    Gabrielle Stetz, Amanda Tse, Gennady M. Verkhivker · 2018 · Scientific Reports
  71. The Hsp90 mosaic: a picture emerges
    Matthias P. Mayer, Chrisostomos Prodromou, Judith Frydman · 2009 · Nature Structural & Molecular Biology
  72. Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90-Targeted Therapy
    S. Alarcon, M. Mollapour, Min-Jung Lee, Shinji Tsutsumi, Sunmin Lee, Y. Kim, T. Prince, A. Apolo, G. Giaccone, Wan-Ping Xu et al. · 2012 · Current molecular medicine
  73. Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells
    Jianhong Yang, Wenshuang Wu, Jiaolin Wen, Haoyu Ye, Hong Luo, Peng Bai, Minghai Tang, Fang Wang, Li Zheng, Shengyong Yang et al. · 2017 · Biomaterials
  74. Hsp90-dependent regulatory circuitry controlling temperature-dependent fungal development and virulence: Hsp90 and fungal development
    O'Meara, Teresa R., Cowen, Leah E. · 2014 · Cellular Microbiology
  75. Activation of the Unfolded Protein Response Contributes toward the Antitumor Activity of Vorinostat
    Soumen Kahali, Bhaswati Sarcar, Bin Fang, Eli S. Williams, John M. Koomen, Philip J. Tofilon, Prakash Chinnaiyan · 2010 · Neoplasia
  76. Requirement of HDAC6 for activation of Notch1 by TGF-β1
    B. Deskin, Joseph A. Lasky, Yan Zhuang, Bin Shan · 2016 · Scientific Reports
  77. Metabolism, cytoskeleton and cellular signalling in the grip of protein Nϵ ‐ and O‐acetylation
    Xiang‐Jiao Yang, Serge Grégoire · 2007 · EMBO Reports
  78. Differences in Conformational Dynamics between Plasmodium falciparum and Human Hsp90 Orthologues Enable the Structure-Based Discovery of Pathogen-Selective Inhibitors
    Tai Wang, William H. Bisson, Pascal Mäser, Léonardo Scapozza, Didier Picard · 2014 · Journal of Medicinal Chemistry
  79. Protein stability and degradation in health and disease
    Lene Clausen, Amanda B. Abildgaard, Sarah K. Gersing, Amelie Stein, Kresten Lindorff‐Larsen, Rasmus Hartmann‐Petersen · 2018 · Advances in protein chemistry and structural biology
  80. Hsp90 Inhibitor 17-DMAG Decreases Expression of Conserved Herpesvirus Protein Kinases and Reduces Virus Production in Epstein-Barr Virus-Infected Cells
    Xiaoping Sun, Jillian A. Bristol, Satoko Iwahori, Stacy R. Hagemeier, Qiao Meng, Elizabeth A. Barlow, Joyce D. Fingeroth, Vera L. Tarakanova, Robert F. Kalejta, Shannon C. Kenney · 2013 · Journal of Virology
  81. Helical Repeat Structure of Apoptosis Inhibitor 5 Reveals Protein-Protein Interaction Modules
    Byeong-Gu Han, Kyoung Hoon Kim, Sang Jae Lee, Kyung-Chae Jeong, Jea‐Won Cho, Kyung Hee Noh, Tae Woo Kim, Soon Jong Kim, Hye Jin Yoon, Se Won Suh et al. · 2012 · Journal of Biological Chemistry
  82. The complementation of yeast with human or Plasmodium falciparum Hsp90 confers differential inhibitor sensitivities
    Diana Wider, Marie‐Pierre Gulli, Pierre-André Briand, Utpal Shashikant Tatu, Didier Picard · 2009 · Molecular and Biochemical Parasitology
  83. Epigenetic Treatment of Neurological Disease
    Steven G. Gray · 2011 · Epigenomics
  84. The complex dance of the molecular chaperone Hsp90
    Len Neckers, Mehdi Mollapour, Shinji Tsutsumi · 2009 · Trends in Biochemical Sciences
  85. HDAC Inhibitors and Chaperone Function
    Rekha Rao, Warren C. Fiskus, Siddhartha Ganguly, Suman Kambhampati, Kapil N. Bhalla · 2012 · Advances in cancer research
  86. Curriculum vitae of HDAC6 in solid tumors
    Yi‐Chao Zheng, Huiqin Kang, Bo Wang, Yuan-Zai Zhu, MAA Mamun, Longfei Zhao, Haiqian Nie, Ying Liu, Lijuan Zhao, Xiaonan Zhang et al. · 2023 · International Journal of Biological Macromolecules
  87. Induction of E-Cadherin in Lung Cancer and Interaction with Growth Suppression by Histone Deacetylase Inhibition
    Masatoshi Kakihana, Tatsuo Ohira, Daniel C. F. Chan, Robin B. Webster, Harubumi Kato, Harry A. Drabkin, Robert M. Gemmill · 2009 · Journal of Thoracic Oncology
  88. The regulatory mechanism of a client kinase controlling its own release from Hsp90 chaperone machinery through phosphorylation
    Xin‐an Lu, Xiaofeng Wang, Wei Zhuo, Lin Jia, Yushan Jiang, Yan Fu, Yongzhang Luo · 2013 · Biochemical Journal
  89. Progress and prospects for targeting Hsp90 to treat fungal infections
    Amanda O. Veri, Leah E. Cowen · 2014 · Parasitology
  90. Establishment of Dimethyl Labeling-based Quantitative Acetylproteomics in Arabidopsis
    Shichang Liu, Fengchao Yu, Zhu Yang, Tingliang Wang, Hairong Xiong, Caren Chang, Weichuan Yu, Ning Li · 2018 · Molecular & Cellular Proteomics
  91. Encephalitis is mediated by ROP18 of Toxoplasma gondii , a severe pathogen in AIDS patients
    Ran An, Yuewen Tang, Lijian Chen, Haijian Cai, De‐Hua Lai, Kang Liu, Lijuan Wan, Linli Gong, Li Yu, Qingli Luo et al. · 2018 · Proceedings of the National Academy of Sciences
  92. Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease
    Linda Anna Michelle Kulka, Pia-Victoria Fangmann, Diana Panfilova, Heidi Olzscha · 2020 · Frontiers in Cell and Developmental Biology
  93. HDAC6-mediated Hsp90 deacetylation reduces aggregation and toxicity of the protein alpha-synuclein by regulating chaperone-mediated autophagy
    Yunlan Du, Xiao Min Yang, Zezhi Li, Weidong Le, Yong Hao, Yeping Song, Fei Wang, Yangtai Guan · 2021 · Neurochemistry International
  94. Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function
    Atul Joshi, Nektarios Barabutis, Charalampos Birmpas, Christiana Dimitropoulou, Gagan Singh Thangjam, Mary Cherian‐Shaw, John Dennison, John D. Catravas · 2015 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  95. Class I histone deacetylases localize to the endoplasmic reticulum and modulate the unfolded protein response
    Soumen Kahali, Bhaswati Sarcar, Antony Herold Prabhu, Edward Seto, Prakash Chinnaiyan · 2012 · The FASEB Journal
  96. A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors
    M New, Heidi Olzscha, Geng Liu, O Khan, Lindsay Stimson, Joanna F. McGouran, David James Kerr, Amanda S. Coutts, Benedikt Mathias Kessler, Mark Ross Middleton et al. · 2013 · Cell Death and Differentiation
  97. Hsp90
    Daniel F. Jarosz · 2015 · Advances in cancer research
  98. Potential Microbiological Effects of Higher Dosing of Echinocandins
    William J. Steinbach, Frédéric Lamoth, Praveen R. Juvvadi · 2015 · Clinical Infectious Diseases
  99. Lysine acetylproteome profiling under water deficit reveals key acetylated proteins involved in wheat grain development and starch biosynthesis
    Gengrui Zhu, Xing Yan, Dong Zi Zhu, Xiong Deng, Jisu Wu, Jian Ling Xia, Yueming Yan · 2018 · Journal of Proteomics
  100. A methylated lysine is a switch point for conformational communication in the chaperone Hsp90
    Rehn, Alexandra, Lawatscheck, Jannis, Jokisch, Marie-Lena, Mader, Sophie L., Luo, Qi, Tippel, Franziska, Blank, Birgit, Richter, Klaus, Lang, Kathrin, Kaila, Ville R. I. et al. · 2020 · Nature Communications